Post by Gubra

We are looking forward to being in Basel, Switzerland next week for Swiss Biotech Day 2026 on May 4–5. Gubra will be there to meet with biotechs, pharma, and investors to discuss future partnership and in-licensing opportunities. Lise Christine Biehl Rudkjær, Senior Director, Business Development & Partnerships, is particularly interested in opportunities within immunology, inflammation and cardiometabolic diseases across therapeutic modalities. Kristoffer Rigbolt, Vice President, Head of Technology Innovation will be attending to explore new technologies and collaboration opportunities that can strengthen our existing services and help shape new initiatives.   Lise and Kristoffer both invite you to reach out to them and connect via the partnering system.   #SwissBiotechDay #Biotech #Partnerships #InLicensing #BusinessDevelopment #Immunology #Inflammation #Cardiometabolic #Obesity #Innovation #Gubra